EPZ-5676 (Pinometostat)
Catalog No. A12735
EPZ-5676 (Pinometostat)是组蛋白甲基转移酶的小分子抑制剂,具有潜在的抗肿瘤活性。
- Yoo H, .et al. Epigenetic priming by Dot1l in lymphatic endothelial progenitors ensures normal lymphatic development and function, Cell Death Dis, 2020, Jan; 11(1): 14 PMID: 31908356
- Guang Bai, .et al. Chapter 1 - Epigenetic Tools in Chronic Pain Studies, Epigenetics of Chronic Pain, 2019, Pages 1-48
Catalog Num | A12735 |
---|---|
M. Wt | 562.7 |
Formula | C30H42N8O3 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1380288-87-8 |
Synonyms | EPZ5676, EPZ 5676 |
SMILES | CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C2N=CN=C3N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C |
EPZ-5676 (Pinometostat)是组蛋白甲基转移酶的小分子抑制剂,具有潜在的抗肿瘤活性。
Targets
DOT1L (Cell-free assay) | ||||
80 pM(Ki) |
In vitro (25°C) | DMSO | Warmed: 88 mg/mL (156.38 mM) | |
Water | Insoluble | ||
Ethanol | Warmed: 81 mg/mL (143.94 mM) | ||
In vivo | 2% DMSO+30% PEG 300+5% Tween 80+ddH2O | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 17.77 mL | 88.86 mL | 177.71 mL |
0.5 mM | 3.55 mL | 17.77 mL | 35.54 mL |
1 mM | 1.78 mL | 8.89 mL | 17.77 mL |
5 mM | 0.36 mL | 1.78 mL | 3.55 mL |
*The above data is based on the productmolecular weight 562.7. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.